Announcement PDF Enlitic, Inc. Appendix 4E Preliminary final report 1. Company details Name of entity: Enlitic, Inc. ARBN: 672 254 027 Reporting period: For the year ended 31 December 2024 Previous period: For the year ended 31 December 2023 2. Results for announcement to the market US$ Revenues from ordinary activities up 129.4% to 1,078,860 Loss from ordinary activities after tax attributable to the owners of Enlitic, Inc. down 2.0% to (15,237,895) Loss for the year attributable to the owners of Enlitic, Inc. down 2.0% to (15,237,895) Dividends There were no dividends paid, recommended or declared during the current financial period. Comments The loss for the Group after providing for income tax amounted to US$15,237,895 (31 December 2023: US$15,551,440). Refer to ‘Review of operations’ in the attached Annual Report for details of the operations for the year. 3. Net tangible assets Net tangible assets per ordinary security 2024 Cents 2023 Cents 1.15 12.67 Group Net assets Less: Right‑of‑use assets Less: Intangibles 2024 US$ 2023 US$ 11,028,200 10,940,363 (109,167) – (4,352,188) (7,175) Add: Lease liabilities 112,378 – Net tangible assets 6,679,223 10,933,188 583,167,692 86,279,385 Total shares issued (number) 4. Control gained over entities Name of entities (or group of entities) Laitek group of companies (refer note 33 and note 34 in the attached Annual Report for details) Date control gained 15 October 2024 US$ Contribution of such entities to the reporting entity’s profit/(loss) from ordinary activities before income tax during the period (where material) (796,574) Profit/(loss) from ordinary activities before income tax of the controlled entity (or group of entities) for the whole of the previous period (where material) – Enlitic, Inc. Appendix 4E 2024 i Enlitic, Inc. Appendix 4E (continued) 5. Loss of control over entities Not applicable. 6. Dividends Current period There were no dividends paid, recommended or declared during the current financial period. Previous period There were no dividends paid, recommended or declared during the previous financial period. 7. Dividend reinvestment plans Not applicable. 8. Details of associates and joint venture entities Not applicable. 9. Foreign entities Details of origin of accounting standards used in compiling the report: Not applicable. 10. Audit qualification or review Details of audit/review dispute or qualification (if any): The financial statements have been audited and the audit report is attached as part of the Annual Report. An unqualified opinion has been issued with a paragraph addressing material uncertainty related to going concern. 11. Attachments Details of attachments (if any): The Annual Report of Enlitic, Inc. for the year ended 31 December 2024 is attached. 12. Signed Darren Scotti Chief Financial Officer and Company Secretary Date: 28 February 2025 ii Enlitic, Inc. Appendix 4E 2024 Empowering the AI‑Driven Healthcare Transformation Annual Report 2024 Who are Enlitic? At Enlitic, we believe that the power of artificial intelligence can transform healthcare by enabling effective data management and improving clinical workflows. Our mission at Enlitic is to revolutionise healthcare by leveraging AI and data, empowering evidence‑based decision‑making, enhancing research, and transforming healthcare delivery. Contents Empowering Healthcare Providers 02 Key Management 21 Empowering Productivity Improvement 04 Directors’ Report 23 Empowering Complex Data Migration 06 Auditor’s Independence Declaration 43 Empowering Innovation and Growth 08 Financial Statements 44 Empowering Value Creation 10 Consolidated Entity Disclosure Statement 85 Chair’s Report 12 Corporate Governance Statement  86 CEO’s Report 14 Directors’ Declaration 88 Industry Overview 16 Independent Auditor’s Report 89 Summary18 Securityholder Information 94 Leadership & Governance Corporate Directory 97 20 Enlitic is at the forefront of the AI‑enabled healthcare revolution. Our commitment to innovation and advancing intelligent data frameworks has led to significant progress in empowering healthcare professionals and improving patient outcomes. By automating routine tasks, accelerating diagnoses, and optimising operations, we have significantly enhanced efficiency and productivity across the sector. As we look to the future, we remain dedicated to pushing the boundaries of AI‑enabled healthcare. Through acquisition and continued investment in research and development, we are poised to deliver groundbreaking solutions that will shape the industry for years to come. Throughout this annual report, we invite you to explore the details of our achievements so far, our resolute focus on empowering healthcare providers and our future plans for growth and value creation. Enlitic, Inc. Annual Report 2024 01 Empowering Healthcare Providers 02 Enlitic, Inc. Annual Report 2024 Transforming Healthcare Delivery Empowering healthcare providers means equipping them with the autonomy, tools, and support needed to make informed decisions and implement actions that enhance patient care and outcomes. High‑quality data plays a crucial role in enabling accurate assessments and insights essential for improving healthcare delivery. As the healthcare landscape evolves, providers will need to harness advanced data and medical imaging technologies to deliver more effective and personalised care. Key Areas of Provider Empowerment 1. Data‑Driven Decision‑Making Leveraging reliable data to inform clinical decisions and improve patient outcomes. 2. Enhanced Medical Imaging Management Utilising cutting‑edge tools to optimise the storage, interpretation, and sharing of medical images. 3. Interoperability and Data Sharing Ensuring seamless data exchange across platforms to foster collaboration and streamline care. By adopting these technologies and strategies, healthcare providers can transform care delivery, improve outcomes, and drive innovation in the industry. Revolutionising Medical Imaging with Ensight Enlitic is at the forefront of empowering healthcare providers with its advanced data standardisation and AI‑enabled solutions for medical imaging. Its flagship software, Ensight 2.0, released ahead of schedule in 2024, delivers a suite of capabilities designed to revolutionise healthcare workflows and data utilisation: 1. Data Standardisation Ensight utilises pixel data and metadata from medical images to generate standardised study and series descriptions, improving data quality and consistency. 2. PHI De‑identification Ensight ensures secure data sharing by anonymising Protected Health Information (PHI) within medical images. 3. Workflow Optimisation By integrating natural language processing and computer vision, Ensight streamlines radiologist reporting workflows, boosting efficiency. 4. AI‑Assisted Diagnostics and Imaging Deploying artificial intelligence to enhance diagnostic accuracy and efficiency. 4. Revenue Generation The framework identifies issues such as contrast billing discrepancies and enhances data value through accurate and consistent labeling, creating new revenue opportunities for providers. 5. Data Unlocking Enlitic addresses the challenge of underutilised healthcare data, enabling providers to access and leverage the 97% of data that traditionally remains untapped. Through its comprehensive capabilities, Enlitic’s Ensight 2.0 empowers healthcare providers to enhance data quality, improve workflow efficiency, and unlock valuable insights from medical imaging data. These advancements pave the way for innovative, effective, and patient‑centred care delivery. 97% of health data produced remains unused * Enlitic is at the forefront of empowering healthcare providers with its advanced data standardisation and AI‑driven solutions for medical imaging. * Source: Health Data | Deloitte Belgium https://www.deloitte.com/be/en/Industries/health-care/research/health-data.html. Enlitic, Inc. Annual Report 2024 03 Empowering Productivity Improvement The Booming Market for AI‑Enabled Solutions Healthcare providers are increasingly turning to advanced technologies to improve productivity in medical imaging and data management. At the forefront of these advancements are AI‑enabled imaging, efficient workflow solutions, and robust data management strategies. These innovations not only enhance operational efficiency but also elevate the quality of patient care. AI‑Enabled Imaging and Analytics Artificial intelligence (AI) is revolutionising image analysis by equipping radiologists with powerful tools to detect anomalies more rapidly and accurately. Key benefits include: • Accelerating image analysis and report generation • Reducing diagnostic errors and false positives; and • Enabling predictive analytics. 04 Enlitic, Inc. Annual Report 2024 Efficient Workflow Solutions Addressing workforce challenges requires the adoption of innovative workflow solutions tailored to the unique needs of healthcare providers. These solutions streamline operations, reduce administrative burdens, and empower clinical teams to focus on patient care. Data Management and Interoperability Effective data management is essential for maximising the value of imaging assets, particularly as medical imaging is expected to constitute 75% of healthcare data by 2025. Healthcare providers will need to adopt strategies that: • Implement robust enterprise imaging frameworks • Enable advanced visualisation through image‑enabled applications; and • Provide quick and seamless access to medical images across formats and systems. By integrating these technologies and practices, healthcare organisations can significantly enhance their productivity, leading to improved patient outcomes and operational efficiency. Enlitic: Leading the Way in Productivity Enhancement Enlitic is proud to empower healthcare providers with cutting‑edge AI‑enabled solutions that optimise medical imaging and data management. With the release of Ensight 2.0 in 2024, Enlitic is setting a new standard in healthcare productivity. Key features include: • Data Standardisation leveraging pixel data and metadata to generate standardised study and series descriptions, ensuring consistent data quality across healthcare systems which leads to improved Data Quality by ensuring data correctness, completeness, and consistency facilitates better data analysis and data orchestration Healthcare organisations can significantly enhance their productivity, leading to improved patient outcomes and operational efficiency. • Workflow Optimisation utilising natural language processing and computer vision to enhance radiologist reporting workflows, reducing reporting time and improving efficiency • Improved Interoperability with standardised data which better supports collaboration among healthcare professionals, addressing interoperability challenges; and • PHI De‑identification that anonymises Protected Health Information (PHI) in medical images, enabling secure data sharing while safeguarding patient privacy. By harnessing the capabilities of Ensight 2.0, healthcare providers can: • Streamline workflows and improve operational efficiency; and • Enhance collaboration and communication across departments and systems. 75% of healthcare data is expected to be medical imaging by 2025 Enlitic remains committed to delivering transformative solutions that empower healthcare providers to achieve greater productivity and deliver exceptional patient care. Enlitic, Inc. Annual Report 2024 05 Empowering Complex Data Migration Advanced Migration Tools and Services AI‑Enabled Data Management Healthcare providers need cutting‑edge solutions that ensure: AI‑enabled tools can enhance migration by: • High success rates cleansing and standardisation in reconciling and migrating data • Rapid migration capabilities; and • Data standardisation to convert proprietary formats into DICOM. • Automating data • Identifying and correcting missing data between disparate PACS and VNAs; and • Completing missing fields to ensure data accuracy. Driving Growth in Data Migration Technology evolves rapidly, necessitating frequent data migrations to help healthcare providers stay current with innovations. However, these migrations can introduce challenges related to cost, speed, and quality. To address these complexities, providers must be empowered with advanced tools and strategies in several key areas: 06 Enlitic, Inc. Annual Report 2024 Comprehensive Planning and Assessment Robust planning tools enable healthcare providers to: • Assess migration needs and define clear project scopes • Evaluate data types, volumes, and timelines; and • Identify risks and resource requirements. Hybrid Migration Approaches Data Integrity and Quality Assurance Interoperability and Standardisation Hybrid strategies help healthcare providers: Healthcare providers should implement tools to: Healthcare providers need solutions that: • Minimise disruptions • Verify data accuracy • Convert data into • Perform quality • Integrate DICOM to clinical operations • Ensure immediate access to patient imaging data; and • Expedite migrations and dependent “go‑lives.” by comparing it to source data assurance checks throughout the migration; and • Validate data completeness and accuracy with patients. standardised formats for compatibility and non‑DICOM data seamlessly; and • Implement industry standards like DICOMweb, HL7, and FHIR. Redefining Data Migration with AI‑Enabled Solutions As a result of Enlitic’s acquisition of Laitek, their combined advanced technologies empower healthcare providers by offering comprehensive migration solutions. This combination accelerates migration speeds, improves data quality, and minimises disruptions. Laitek’s service enables faster data transfer and ensures standardised outputs, unlocking historical data archives for enhanced clinical value. With a remarkable 96‑99% success rate, Laitek simplifies new PACS configuration, streamlines transitions, and ensures immediate data access. By leveraging these capabilities, Enlitic enables healthcare providers to manage complex migrations efficiently, ensuring data integrity, accessibility, and full utilisation of medical imaging data. Enlitic, Inc. Annual Report 2024 07 Empowering Innovation and Growth 08 Enlitic, Inc. Annual Report 2024 Enlitic: AI‑Enabled Data Standardisation and Migration Solutions Enlitic empowers healthcare providers to drive innovation and growth through advanced data standardisation and migration solutions. Interoperability and Innovation By standardising medical imaging data, Enlitic enables: • Seamless integration between systems • Improved collaboration among healthcare professionals AI‑Enabled Data Standardisation • Enhanced research Enlitic’s ENDEX platform uses artificial intelligence to standardize medical imaging data, enabling: • Foundation for AI algorithm • Consistent hanging protocols, improving radiologist efficiency capabilities; and development. Data Quality and Integrity Enlitic’s ENDEX ensures: • Accurate data routing, reducing • Consistent and accurate • Enhanced searchability • Improved data quality for • Improved billing accuracy. • Enhanced reliability for bandwidth consumption for researchers; and Comprehensive Data Management Enlitic’s intelligent data framework: medical imaging data AI orchestration; and clinical decision‑making. Search and Cohort Development of archived information ENABLE is an advanced module designed to transform how healthcare institutions interact with medical imaging data. • Unlocking new revenue • Reduces cohort development • Orchestrates critical workflows • Enhances comprehension opportunities • Generates cost savings; and • Improve healthcare delivery. Efficient Data Migration Enlitic’s solutions offer: • High success rates (96‑99%) in reconciling and migrating data • Rapid migration capabilities, transferring data 5‑10 times faster than traditional methods; and • Data standardisation features to convert proprietary formats into standard DICOM 3.0. Privacy and Security Ensured ENCOG, an AI‑enabled data anonymisation solution designed to protect Protected Health Information (PHI) while retaining clinically relevant data in medical imaging studies. • Leverages Natural Language Processing (NLP) and Computer Vision (CV) to accurately differentiate PHI from essential clinical information • ENCOG removes PHI from both DICOM metadata and pixel data (burn‑ins), while maintaining the historical associations of patient studies; and • Efficient anonymisation for single studies or batch processes. By leveraging Enlitic’s solutions, healthcare providers can transform their data management practices, leading to improved operational efficiency, better patient outcomes, and new opportunities for innovation and growth in the rapidly evolving healthcare landscape. time from weeks to minutes for clinical trials and quality initiatives • Enables access to high‑quality data for advanced data analytics • Enhances data monetisation through the creation of de‑identified, disease‑specific datasets for research partnerships; and • Supports radiation dose monitoring, rare disease tracking, and population health management via customisable dashboards. Enlitic, Inc. Annual Report 2024 09 Empowering Value Creation Make Your Data Work for You Enlitic empowers healthcare providers to create significant value from their medical imaging and data migration through several innovative solutions: AI‑Enabled Data Standardisation Enlitic’s ENDEX platform uses artificial intelligence to standardise medical imaging data, enabling: • Consistent hanging protocols, improving radiologist efficiency • Accurate data routing, reducing bandwidth consumption • Enhanced searchability for researchers and clinicians; and • Improved billing accuracy with alerts for under‑coding. 10 Enlitic, Inc. Annual Report 2024 Advanced Data Migration With the acquisition of Laitek, Enlitic now offers: • High success rates (96‑99%) in reconciling and migrating data • Rapid migration capabilities, transferring data 5‑10 times faster than traditional methods; and Enhanced Data Quality and Integrity The combination of Enlitic’s and Laitek’s technologies ensures: • Advanced data validation and cleansing during migration • Improved accuracy and completeness of migrated data; and • Data standardisation features to • Standardised study and series Data Monetisation Opportunities Streamlined Workflows and Efficiency Enlitic enables healthcare providers to: Healthcare providers benefit from: convert proprietary formats into standard DICOM 3.0. • Broker anonymised, standardised data to clinical research organisations or pharmaceutical companies; and • Generate new revenue By leveraging Enlitic’s comprehensive solutions, healthcare providers can transform their medical imaging data into a valuable asset, driving innovation, improving patient care, and creating new opportunities for growth and revenue generation. descriptions for consistency and correctness. • Reduced time spent on mundane data management tasks • Improved radiology workflows through standardised data; and • Enhanced comprehension of 5–10X Data transfer times 5‑10 times faster than traditional methods archived information. streams from existing medical imaging archives. Enlitic, Inc. Annual Report 2024 11 Chair’s Report Dear Shareholders, On behalf of the Board of Directors and Management of Enlitic, Inc. I am pleased to present the Annual Report for the financial year ended 31 December 2024. Lawrence Gozlan Chairman Enlitic is a software development company using artificial intelligence to manage medical imaging data in radiology and licenses its products to healthcare providers and original equipment manufacturers. Its technology features a host of AI‑enabled modules that enable data standardisation, de‑identification, anonymisation and workflow simplification. Through our recent acquisition of Laitek which was completed during the year, Enlitic is also now a significant provider of tech‑enabled healthcare medical imaging data migration and routing services. In early June 2024 Enlitic released key components of Ensight 2.0, 18 months ahead of our development schedule. 12 Enlitic, Inc. Annual Report 2024 2024 has been a transformative year for Enlitic following its listing on the Australian Stock Exchange in December 2023. The company has built significantly on its foundations and is now well positioned to accelerate its position as a leader in healthcare medical imaging data standardisation, data anonymisation and data migration. I would like to thank each and every one of our team for the enormous effort they put in to build our success. Continuing our focus on product development, in early June 2024 we released key components of Ensight 2.0, 18 months ahead of our development schedule. Ensight 2.0 deidentifies Protected Health Information in medical images and improves data quality, which enables healthcare providers to realise value from an increasing number of use cases and improves radiologist reporting workflows. We saw continued momentum in our sales progress during the year, signing up healthcare providers and OEM healthcare vendors and distributors to software licenses and vendor agreements. We entered into 16 new agreements with the following organisations: US$1.08m Enlitic’s FY24 revenue • Healthcare providers: Unilabs, Royal National Orthopaedic Hospital NHS Trust, National Cancer Center Japan, Northern Lights Medical Management LLC • OEM Healthcare Vendors: Philips Healthcare, Bayer, Medica Group, Emory University • Distributors: Biotronics 3D Limited, Testdynamics Holdings Inc, Esaote, DataFirst, DMC Healthcare, UltraRAD, Darwinist, New Vue Inc Enlitic’s FY24 revenue was US$1.08 million compared to US$0.47 million in FY23, a marked increase as the Company concentrated its efforts on driving growth in new client agreements and worked to onboard newly signed customers. As the onboarding process is dependent on factors including customer resources and systems, implementation timelines are varied and revenue conversation in the early stages of commercialisation is uneven. One of our primary focus points in 2025 is reducing time to deployment following the execution of client contracts. 1. In the fourth quarter of the year, Enlitic successfully completed A$23.4 million in financing, having raised A$22.5 million via a conditional placement in October 2024 and the completion of a $906k non‑underwritten security purchase plan in November 2024. Part of the funds raised were used to acquire Laitek, Inc, one of the major providers of tech‑enabled healthcare medical imaging data migration and routing services in the US. The Company purchased 100% of the shares in Laitek for cash and scrip consideration, totalling US$4.95 million (c. A$7.3 million1). The Laitek acquisition is pivotal for Enlitic, bringing us significant access to new clients as well as compelling potential revenue synergies and cost savings. Due to investing heavily in the growth of the Company, LBIT was US$15.4m in FY24, broadly inline with FY23 at US$15.6m. Enlitic remains focused on driving operational efficiencies within the organisation. One off costs associated with the capital raise and SPP as well as the acquisition of Laitek were incurred during the year, while synergy savings of approximately US$1.0m were implemented by the end of Q4 2024. Early in 2024, we welcomed Lisa Pettigrew to the Board of Directors, bringing a unique entrepreneurial skillset in the healthcare and technology sectors to the Company. We also farewelled Riichi Yamada in late 2024 with great thanks for his service as an NED and wished him well for the future. On behalf of the Board, I would like to thank you for your ongoing support and interest in Enlitic. We are committed to driving Enlitic forward to providing better data quality and migration solutions for our healthcare customers. With the passing of each year, we are forging deeper relationships with new and existing clients and partners and seeing greater recognition of our value potential. We will continue to execute on our strategy of improving the utility and value of medical imaging data for our clients and unlocking the true value of our business. Yours sincerely, Lawrence Gozlan Chairman of the Board Enlitic, Inc. Exchange rate at the time of posting as per ASX announcement: https://app.sharelinktechnologies.com/announcement/ asx/1fc3dc6cbc7edf6208790be2e301ba13 Enlitic, Inc. Annual Report 2024 13 CEO’s Report Dear Shareholders, 2024 has been a transformative year for Enlitic. We expanded and restructured our business to establish ourselves as leaders in AI‑driven medical imaging data management and migration. Michael Sistenich Chief Executive Officer 14 Enlitic, Inc. Annual Report 2024 Since listing on the Australian Stock Exchange in December 2023, we have made significant strides. We grew our customer base, forged key partnerships, and completed the strategic acquisition of Laitek Inc., a major provider of tech‑enabled healthcare medical imaging data migration and routing services in the U.S. Throughout, we remained focused on our mission: empowering evidence‑based decisionmaking, enhancing research, and transforming healthcare data delivery. We set three key operational priorities at the start of 2024: improving operational efficiencies, enhancing our product suite, and accelerating customer growth through direct and partnership channels. I am pleased to report that we achieved all three. Additionally, we seized the opportunity to acquire Laitek Inc., a strategic move that broadens our product range and accelerates our commercial development. Beyond its leadership in data migration, Laitek has strengthened our commercial pipeline by generating valuable sales leads and expanding our use cases. We funded this acquisition with strong shareholder support, using part of the funds raised through a successful A$22.5 million Placement and a A$906k through a Share Purchase Plan in Q4 2024. Since listing on the Australian Stock Exchange in December 2023, we have made significant strides. By implementing cost control measures and synergy savings, we achieved approximately US$1.0 million in savings during 2024. During Laitek’s integration, we identified and executed an additional US$1.0 million in savings in January 2025. In June 2024, we proudly launched key components of our product suite, Ensight 2.0. Delivering it 18 months ahead of schedule significantly expanded Enlitic’s use case offerings. Following its release, our sales process accelerated, drastically reducing the time from initial engagement to contract signing as customers embraced the new product. We sustained this commercial momentum in the latter half of the year, signing agreements with Philips Healthcare, Bayer Healthcare, and the National Cancer Centre Japan, among others, and attending RSNA 2024, the world’s leading imaging conference in Chicago. In 2025, we will focus on onboarding newly contracted clients to drive revenue growth through recurring licensing fees and project fees. At the same time, we will advance our go‑to‑market strategy by partnering with healthcare and health‑tech leaders to develop better solutions for providers and patients. On behalf of the Board and Management of Enlitic, I want to thank our dedicated team for their commitment to improving medical imaging data quality, access, versatility, and migration. Finally, I extend my gratitude to our securityholders for your continued support. We look forward to keeping you updated on our progress throughout 2025. Sincerely, US$1.0m Approximate delivered savings during 2024 Michael Sistenich Chief Executive Officer Enlitic, Inc. Enlitic, Inc. Annual Report 2024 15 Industry Overview $14.2b+ The global medical imaging market is projected to grow by USD 14.2 billion from 2024‑20283. 16 Enlitic, Inc. Annual Report 2024 The medical imaging industry experienced significant growth and technological advancements. As we move into 2025, some key trends and developments will develop and include: AI Integration and Advanced Technologies Mobile and Accessible Imaging Artificial intelligence is revolutionising medical imaging, enhancing diagnostic accuracy and efficiency. AI‑enabled analysis tools are reducing diagnosis time by up to 30%2. The AI segment in medical imaging is expected to grow from $762 million in 2022 to approximately $14.4 billion by 20322. AI is on the cusp of going mainstream. Radiology leads the way in for healthcare in FDA approved AI based medical devices3. Mobile medical imaging technologies are enabling swift and cost‑effective diagnostic services in remote areas. Web‑based enterprise imaging systems are replacing traditional PACS, allowing clinicians to access images and reports from anywhere5. The push for data interoperability is driving healthcare IT investments, particularly in the US, as providers aim to comply with federal standards like the 21st Century Cures Act. Market Growth and Innovation The industry is seeing robust expansion due to increasing healthcare expenditure and growing demand for diagnostic services. The global medical imaging market is projected to grow by USD 14.2 billion from 2024‑20284. Hospitals and clinics prioritise solutions that reduce costs and improve patient outcomes. AI‑enabled solutions that optimise workflows align perfectly with this trend. Radiologist Shortage As the practicing radiologist workforce ages, it will become more difficult to staff adequately – imaging volumes continue to increase at the sa